Paul LaViolette will join us at the 2021 Emerging Medtech Summit during a Fireside Chat to kick off the event. He'll also attend the event to network and connect with other investors, innovators and strategics.
LaViolette has over 35 years of global medical technology management experience. He is an active investor, industry insider and sits on the Board of several medical device companies. He also currently serves as Managing Partner & COO of SV and heads up their medical device investments.
Prior to SV, Paul built and ran medical device businesses for 29 years before joining SV Health Investors. Most recently he was Chief Operating Officer at Boston Scientific (BSC), an $8 billion medical device leader. During his 15 years at BSC, Paul served as Chief Operating Officer; Group President, Cardiovascular; President, Cardiology; Group President, Endosurgery; and President, International. During his tenure, the company grew revenue over 20 times. Paul integrated two dozen acquisitions and led extensive product development, manufacturing and worldwide commercial organizations. Previously, Paul held marketing and general management positions at CR Bard and various marketing roles at Kendall (Medtronic).
Outside of SV, Paul serves as Chairman of the Medical Device Manufacturing Association and as Vice Chairman of the Innovation Advisory Board for the Partners Health System. Paul also served on the board of Advamed for 10 years and is a routine speaker at industry meetings.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
